Central Bank of India shareholders approve ₹7,000 crore equity raise
Central Bank of India shareholders approved a ₹7,000 crore equity raise via special resolution at its 19th AGM on July 31, 2026. The bank also confirmed interim dividends of ₹1.20 per share for FY25-26 and appointed Kalyan Kumar as MD & CEO. All resolutions passed with over 98% assent.

*this image is generated using AI for illustrative purposes only.
Shareholders of central bank of india approved a special resolution to raise equity capital up to ₹7,000 crore at its 19th Annual General Meeting (AGM) held on July 31, 2026. The resolution, which permits the bank to raise funds through Qualified Institutional Placement (QIP), Follow-on Public Offer (FPO), or rights issues, secured 99.26% assent from voting shareholders. This approval provides the board with the flexibility to execute capital raising measures necessary for balance sheet strengthening or growth initiatives in the coming fiscal periods.
The AGM was conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM) with a deemed venue at Chandermukhi, Nariman Point, Mumbai. S. N. Ananthasubramanian & Co., led by Managing Partner S. N. Viswanathan, served as the scrutinizer for the remote e-voting process. Voting rights were reckoned as of July 24, 2026, with remote e-voting open from July 27 to July 30, 2026. MUFG Intime India Private Limited acted as the e-voting agency.
In addition to the capital raise, shareholders passed seven ordinary resolutions. Key outcomes included the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the confirmation of four interim dividends aggregating to ₹1.20 (12%) per equity share of face value ₹10 each for FY25-26. This dividend payment received 99.68% support from shareholders.
The meeting also addressed significant changes to the Board of Directors. Shareholders approved the appointment of Kalyan Kumar as Managing Director and Chief Executive Officer (MD & CEO) effective September 30, 2025, for a three-year term. Additionally, E. Ratan Kumar was appointed as an Executive Director effective November 24, 2025, also for a three-year term. The term of Executive Director M V Murali Krishna was extended beyond his existing notified term ending November 30, 2025, until his superannuation date of July 31, 2027, or until further orders.
Government nominee director appointments were also ratified. Baldeo Purushartha was appointed as a Non-Executive Government Nominee Director effective July 24, 2025, until June 19, 2026. Chandradeep Kumar Jha was appointed as a Non-Executive Government Nominee Director effective June 19, 2026, until further orders. Both resolutions received overwhelming support, with dissent votes below 1.12%.
AGM Resolution Outcomes
| Agenda Item | Resolution Type | Key Detail | Assent % |
|---|---|---|---|
| 1 | Ordinary | Adoption of FY25-26 Financial Statements | 99.61% |
| 2 | Ordinary | Confirmation of ₹1.20 per share interim dividend | 99.68% |
| 3 | Ordinary | Appointment of Baldeo Purushartha as Govt. Nominee Director | 99.99% |
| 4 | Ordinary | Extension of M V Murali Krishna’s term as Executive Director | 98.90% |
| 5 | Ordinary | Appointment of Kalyan Kumar as MD & CEO | 99.55% |
| 6 | Ordinary | Appointment of E. Ratan Kumar as Executive Director | 98.99% |
| 7 | Ordinary | Appointment of Chandradeep Kumar Jha as Govt. Nominee Director | 98.88% |
| 8 | Special | Approval to raise equity capital up to ₹7,000 crore | 99.26% |
What the Numbers Show
The near-unanimous support for the ₹7,000 crore equity raise (99.26%) signals strong shareholder confidence in the bank’s capital deployment strategy. With no single shareholder other than the Central Government holding more than 10% of voting rights, the broad base of support suggests alignment between retail/institutional investors and management on the need for capital adequacy or expansion. The high assent rates across all board appointments further indicate stability in governance expectations.
Historical Stock Returns for Central Bank of India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.16% | +0.06% | -4.80% | -17.26% | -15.59% | +27.45% |
How will the ₹7,000 crore capital infusion specifically impact Central Bank of India's Capital Adequacy Ratio (CAR) and its ability to meet Basel III norms in the coming fiscal years?
What is the strategic rationale behind the board's choice between QIP, FPO, or rights issues for the equity raise, and how might each option affect existing shareholder dilution?
Given the appointment of Kalyan Kumar as MD & CEO, what specific growth initiatives or risk management strategies are expected to be prioritized during his three-year tenure?


































